Pharmacology bioRxiv
Colon organoids show how microvilli shape drug uptake into cells
- Preprint: human colon-derived 3D organoids were built as an in vitro model for colonic drug handling, a gap since most organoid ADME work uses small intestine.
- Proteomics, imaging, lipidomics and functional assays showed isolated primary epithelial cells are a better native benchmark than whole tissue; the organoids resembled it closely.
- Intracellular drug availability depended on lipophilicity and microvilli, and colonoids differed from HEK293 cells in membrane lipid content and drug binding.
Colon is where modified-release and poorly absorbed drugs actually act, so a colonoid that tracks isolated native epithelium is more useful than yet another ileum-flavored model. But the benchmark is the weak link: no one has shown it predicts human colonic exposure. Test it with a few compounds whose luminal or biopsy concentrations are known, and add efflux-inhibitor controls before trusting the P-gp/BCRP readouts.
Paper: bioRxiv ↗ Native-like 3D colonoids reveal mechanisms of colonic drug disposition